JPH07504669A - - Google Patents

Info

Publication number
JPH07504669A
JPH07504669A JP51618193A JP51618193A JPH07504669A JP H07504669 A JPH07504669 A JP H07504669A JP 51618193 A JP51618193 A JP 51618193A JP 51618193 A JP51618193 A JP 51618193A JP H07504669 A JPH07504669 A JP H07504669A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51618193A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK36492A priority Critical patent/DK36492D0/da
Application filed filed Critical
Priority to PCT/DK1993/000098 priority patent/WO1993018785A1/en
Publication of JPH07504669A publication Critical patent/JPH07504669A/ja
Application status is Pending legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
JP51618193A 1992-03-19 1993-03-18 Pending JPH07504669A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK36492A DK36492D0 (da) 1992-03-19 1992-03-19 Praeparat
PCT/DK1993/000098 WO1993018785A1 (en) 1992-03-19 1993-03-18 Novel medicament

Publications (1)

Publication Number Publication Date
JPH07504669A true JPH07504669A (zh) 1995-05-25

Family

ID=8092684

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51618193A Pending JPH07504669A (zh) 1992-03-19 1993-03-18

Country Status (6)

Country Link
EP (1) EP0631504A1 (zh)
JP (1) JPH07504669A (zh)
KR (1) KR957000754A (zh)
AU (1) AU3888793A (zh)
DK (1) DK36492D0 (zh)
WO (1) WO1993018785A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002532557A (ja) * 1998-12-22 2002-10-02 イーライ・リリー・アンド・カンパニー グルカゴン様ペプチド−１の貯蔵安定性製剤
JP2007518722A (ja) * 2003-12-26 2007-07-12 ナステック ファーマスーティカル カンパニー インク． グルコース調節ペプチドの鼻腔内投与

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614492A (en) * 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
RU2128663C1 (ru) * 1992-06-15 1999-04-10 Скиос Инк. Производные полипептида, обладающие инсулинотропной активностью, фармацевтическая композиция, способы усиления действия инсулина, способы лечения диабета
NZ250844A (en) * 1993-04-07 1996-03-26 Pfizer Treatment of non-insulin dependant diabetes with peptides; composition
US6284727B1 (en) 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US6852690B1 (en) 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
DE19530865A1 (de) * 1995-08-22 1997-02-27 Michael Dr Med Nauck Wirkstoff sowie Mittel zur parenteralen Ernährung
AT356830T (de) 1996-08-30 2007-04-15 Novo Nordisk As Glp-1 derivate
JP2001525371A (ja) 1997-12-05 2001-12-11 イーライ・リリー・アンド・カンパニー Ｇｌｐ−１製剤
AU3247799A (en) 1998-02-27 1999-09-15 Novo Nordisk A/S Glp-1 derivatives of glp-1 and exendin with protracted profile of action
JP2002512175A (ja) 1998-02-27 2002-04-23 ノボ ノルディスク アクティーゼルスカブ Ｇｌｐ−１類似体の誘導体類
AT466026T (de) 1998-02-27 2010-05-15 Novo Nordisk As Derivate von glp-1 und exendin mit verlängertem wirkdauer-profil
EP1062240B1 (en) 1998-02-27 2010-04-28 Novo Nordisk A/S N-terminally modified glp-1 derivatives
EP1306091A3 (en) 1998-07-31 2003-05-21 Novo Nordisk A/S Stimulation of beta cell proliferation
US6720407B1 (en) 1998-08-28 2004-04-13 Eli Lilly And Company Method for administering insulinotropic peptides
EP1666054A1 (en) * 1998-08-28 2006-06-07 Eli Lilly & Company Method for administering insulinotropic peptides
CO5090908A1 (es) * 1998-08-28 2001-10-30 Lilly Co Eli Procedimiento para administrar peptidos insulinotropicos
DE60114996T2 (de) 2000-03-08 2006-08-10 Novo Nordisk A/S Senkung des serum cholesterols
ES2298378T3 (es) 2001-06-28 2008-05-16 Novo Nordisk A/S Formulacion estable de glp-1 modificado.
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
PL1633391T3 (pl) 2003-06-03 2012-03-30 Novo Nordisk A/S Stabilizowane farmaceutycznie kompozycje peptydowe
US20070203058A1 (en) 2003-09-19 2007-08-30 Novo Nordisk A/S Novel Glp-1 Derivatives
EP3300721B1 (en) 2003-11-20 2019-03-06 Novo Nordisk A/S Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
WO2007065156A2 (en) * 2005-12-02 2007-06-07 Nastech Pharmaceutical Company Inc. Pharmaceutical formulation for increased epithelial permeability of glucose-regulating peptide
CA2586771A1 (en) 2004-11-12 2006-05-18 Novo Nordisk A/S Stable formulations of insulinotropic peptides
AU2005311099B2 (en) 2004-12-02 2012-02-02 Domantis Limited Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
WO2007061434A2 (en) * 2005-11-10 2007-05-31 Nastech Pharmaceutical Company Inc. A pharmaceutical formulation of glp-1 and its use for treating a metabolic syndrome
EP2259802A1 (en) 2008-03-31 2010-12-15 Glaxo Group Limited Drug fusions and conjugates
AU2010227552B2 (en) 2009-03-27 2015-02-26 Glaxo Group Limited Drug fusions and conjugates
EP2483308A1 (en) 2009-09-30 2012-08-08 Glaxo Group Limited Drug fusions and conjugates with extended half life
WO2012136790A1 (en) 2011-04-07 2012-10-11 Glaxo Group Limited Compositions comprising fusion proteins or conjugates with an improved half -life
WO2012136792A2 (en) 2011-04-07 2012-10-11 Glaxo Group Limited Cck compositions
WO2013083826A2 (en) 2011-12-09 2013-06-13 Novo Nordisk A/S Glp-1 agonists
GB201308753D0 (en) * 2013-05-15 2013-06-26 Stichting Nl Kanker Inst Compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
ES2089011T3 (es) * 1989-02-17 1996-10-01 Liposome Co Inc Excipiente lipidico de administracion nasal y aplicacion topica.
GB8918879D0 (en) * 1989-08-18 1989-09-27 Danbiosyst Uk Pharmaceutical compositions
DK0512042T3 (da) * 1990-01-24 1998-05-11 Douglas I Buckley GLP-1-analoger anvendelige ved diabetesbehandling

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002532557A (ja) * 1998-12-22 2002-10-02 イーライ・リリー・アンド・カンパニー グルカゴン様ペプチド−１の貯蔵安定性製剤
JP4689833B2 (ja) * 1998-12-22 2011-05-25 イーライ リリー アンド カンパニー グルカゴン様ペプチド−１の貯蔵安定性製剤
JP2007518722A (ja) * 2003-12-26 2007-07-12 ナステック ファーマスーティカル カンパニー インク． グルコース調節ペプチドの鼻腔内投与

Also Published As

Publication number Publication date
WO1993018785A1 (en) 1993-09-30
EP0631504A1 (en) 1995-01-04
DK36492D0 (da) 1992-03-19
AU3888793A (en) 1993-10-21
KR957000754A (ko) 1995-02-20

Similar Documents

Publication Publication Date Title
JPH07501746A (zh)
JPH07505587A (zh)
DE9203662U1 (zh)
JPH06504886A (zh)
TW255980B (zh)
TW240289B (zh)
JPH07503754A (zh)
JPH07508343A (zh)
TW248567B (zh)
TW260675B (zh)
JPH04125427U (zh)
JPH06509888A (zh)
JPH07508888A (zh)
JPH07509026A (zh)
DE9202151U1 (zh)
DE9300846U1 (zh)
DE9205607U1 (zh)
DE9205898U1 (zh)
DE9206752U1 (zh)
FR2692226B1 (zh)
DE9200788U1 (zh)
EP0575665A3 (zh)
TW222235B (zh)
DE9214137U1 (zh)
TW210417B (zh)